Vulvar Carcinoma — Trials

Vulvar Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

52 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 13
Ph III recruiting: 0
Growth YoY: —
Industry share: 31%
Top sponsor: Christian Hinrichs
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03452332	Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers	completed	Phase 1	20	M.D. Anderson Cancer CenterOTHER	1	Sep 13, 2023	clinicaltrials
NCT03517488	A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors(DUET-2)	completed	Phase 1	150	Xencor, Inc.INDUSTRY	1	Dec 1, 2022